Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers | Synapse
August 15, 2024Open Access
Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.